found to contribute to the formation of the DHP receptor Jö rg Striessnig, and Hartmut Glossmann site on the ␣1S subunit (Nakayama et al., 1991; Striessnig Institut fü r Biochemische Pharmakologie et al., 1991; Catterall and Striessnig, 1992). These comUniversitä t Innsbruck prised parts of the pore-lining S5-S6 linkers (P or SS Peter Mayrstraße 1 regions) together with transmembrane segments S6 of A-6020 Innsbruck repeats III (IIIS6) and IV (IVS6). Together with electroAustria physiological studies (Kass and Arena, 1989; Kass et al., 1991; Strü bing et al., 1993) , these data provided evidence that regions close to segment IIIS6 and near the extracellular pore opening form the core of the DHP Summary receptor site.
Introduction we favored a ''constructive'' method. Here, we transposed sequence stretches from two distinct classes of In excitable cells, intracellular concentrations of free DHP-sensitive L-type channel ␣1 subunits, namely from Ca 2ϩ are regulated via voltage-dependent Ca 2ϩ chanrabbit heart ␣ 1C (Mikami et al., 1989) and carp (Cyprinus nels. These channels can be distinguished according to carpio) skeletal muscle ␣ 1S (Grabner et al., 1991) into biophysical and pharmacological criteria into different the corresponding regions of the DHP-insensitive rabbit types (L, P, N, R, Q, and T; Birnbaumer et al., 1994;  brain ␣ 1A (BI-2) channel . Chimeric chan- Dunlap et al., 1995) . At least three classes of ␣ 1 subunits, nels were studied for DHP agonist and antagonist sensiencoded by different genes, participate in the formation tivity after heterologous expression in Xenopus laevis of L-type channels: class S in skeletal muscle; class C oocytes. Our final goal was to create a DHP agonistin smooth muscle, cardiac muscle, and neurons; and and DHP antagonist-sensitive ␣1 chimeric construct class D in neuroendocrine cells (reviewed in Hofmann containing only a minimal quantity of L-type sequence et al., 1994). They can be discriminated from all other (''minimum chimera''). Ca 2ϩ channel types by their sensitivity to 1,4-dihydropyOur results demonstrate that 9.4% of L-type ␣ 1 seridines (DHPs). These drugs label a high affinity DHP quence, covering transmembrane segments IIIS5 and receptor domain located on the channel's ␣ 1 subunit IIIS6, including their connecting linker (pore loop), to- (Catterall et al., 1988; Glossmann and Striessnig, 1990) .
gether with a second motif comprising the IVS5-IVS6 Some DHPs act as ''Ca 2ϩ antagonists'' or channel blocklinker plus transmembrane segment IVS6, are sufficient ers (e.g., isradipine, nifedipine, nimodipine), preferento introduce DHP agonist and antagonist sensitivity into tially stabilizing the inactivated state of the channel, ␣1A. Biophysical and pharmacological properties of this whereas others (e.g., Bay K 8644) are ''Ca 2ϩ agonists'' minimum chimera were studied and compared with (channel activators) and promote the open state (Hess, channels entirely composed of L-type sequence. Subse-1990; Hille, 1992) .
quently, we identified distinct regions responsible for To gain a deeper insight into the molecular mechanism agonist or antagonist action within these ''minimum moof L-type channel modulation by DHPs, attempts were tifs.'' Delineating the architecture of the DHP-agonist made to elucidate the structural details of the DHP bindand DHP-antagonist interaction sites on the level of indiing domain(s). With peptide mapping techniques after photolabeling, two distant sequence stretches were vidual amino acids now seems possible. Figure 2 ). As observed with native L-type channels, Bay K 8644 increased peak I Ba ; slowed Mapping the Sequence Motifs Responsible for DHP current activation; shifted the peak, as well as the midSensitivity of L-Type ␣1 Subunits point voltage of the current activation curve to more To determine the regions mediating DHP sensitivity in negative potentials; and slowed tail currents (Figure 2 ). L-type calcium channels, we introduced sequence Current block by the DHP antagonist (Ϯ)-isradipine (10 stretches from two different DHP-sensitive L-type chan-M) was accompanied by an acceleration of current nel ␣ 1 subunits into the DHP-insensitive ␣ 1A (Mori et al., decay ( Figure 2 ) and a shift of the steady-state inactiva-1991). All chimeras were coexpressed in X. laevis ootion curve toward more negative voltages (data not cytes, together with the ␤1A subunit. Ca 2ϩ channel ␤ shown). Despite the pronounced differences in current subunits are known to enhance channel function (curkinetics between Lh and Ls, similar changes in the voltrent amplitudes, drug binding) and also to affect current age-dependence of I Ba were induced by Bay K 8644. The kinetics (Lacerda et al., 1991; Mori et al., 1991;  Varadi observed shift in the voltage dependence of activation to et Wei et al., 1991; Grabner et al., 1994; Mitter- negative potentials was, however, less pronounced for dorfer et al., 1994) . Figure 1A gives a schematic strucchimera Ls (Figures 2A and 2B ). tural overview and Figure 1B , an overview on the sensiThe effect of the antagonist isradipine on I Ba inactivativity of the resulting chimeras toward DHP agonists and tion was most prominent for the slowly activating chiantagonists, respectively. The DHP-sensitive ␣ 1 submera Ls. Under control conditions, current did not reach units used for chimerization were ␣ 1C from rabbit heart its peak during a 350 ms test pulse ( Figure 2B ) (see also (Mikami et al., 1989) and ␣ 1S from carp skeletal muscle Wang et al., 1995) but ''inactivated'' in the presence (Grabner et al., 1991) . Similar to ␣ 1S from rabbit skeletal of 10 M (Ϯ)-isradipine ( Figure 2B ). Therefore, these muscle (Tanabe et al., 1987) , ␣ 1S from carp skeletal musisradipine induced changes in current kinetics, especle could not be functionally expressed in Xenopus oocially of the slowly activating chimeras, precluded a cytes. However, after replacing repeats I and II of carp comparison of the drug effects ( Figure 1B ) by measuring ␣ 1S with the corresponding ␣ 1C sequences, this construct inhibition of peak current values. Antagonist effects of (termed Ls in Figure 1A ) formed DHP agonist-and DHP isradipine were therefore evaluated as current inhibition antagonist-sensitive channels ( Figure 1B and Figure 2) .
Results

agonist (Ϯ)-Bay K 8644 (10 M) and blocked by (Ϯ)-isradipine (10 M;
at the end of a 350 ms test pulse to ϩ20 mV. Taking In contrast, a construct (data not shown) that contained into account that the agonist effects on I Ba were always repeats I and II from ␣ 1C and repeats III and IV from ␣ 1A more pronounced in the voltage range from Ϫ10 to 0 remained DHP insensitive like ␣ 1A . Clearly, repeats I and mV, we assessed DHP agonist effects on I Ba as the in-II alone do not determine DHP sensitivity, but repeats crease in maximum current amplitude during a 350 ms III and IV of carp ␣ 1S supported DHP sensitivity and could test pulse to Ϫ10 to 0 mV ( Figure 1B ). therefore be for used for chimerization. As previously Previous work suggested that the pore regions and described (Wang et al., 1995) the expression of ␣ 1C was adjacent transmembrane segments S6 of repeats III and improved by replacing parts of its N-terminus with carp IV of skeletal muscle ␣ 1S play a key role for the formation ␣ 1S sequence. The respective construct is termed Lh.
of the DHP receptor site (Nakayama et al., 1991 ; StriessAlso, chimera Ls contained the carp ␣ 1S N-terminal senig et al., 1991; Tang et al., 1993) . Consequently, chimera quence. AL1 ( Figure 1A ) was constructed where these regions Figure 2 illustrates electrophysiological properties were replaced in ␣ 1A by the corresponding carp ␣ 1S and DHP sensitivity of Lh (Figure 2A ), Ls ( Figure 2B ), L-type sequences. AL1 displayed kinetic properties typiand ␣ 1A ( Figure 2C ). Ls activated significantly more cal for ␣ 1A Sather et al., 1993) but slowly than the other constructs. A detailed comparison surprisingly was insensitive to 10 M of the DHP agonist of the kinetic properties of Lh and Ls has been published (Ϯ)-Bay K 8644 or the antagonist (Ϯ)-isradipine (Figure recently (Wang et al., 1995) . In contrast to the other 1B). Clearly, additional regions are required to mediate constructs, Ba 2ϩ inward currents (I Ba ) through ␣ 1A DHP sensitivity. As for ␣ 1A (see above), replacement of showed significant inactivation of typically 35%-50% of repeats I and II by ␣ 1C sequence in AL2 ( Figure 1A ) did the current after a 350 ms test pulse to ϩ10 mV. Inward not support DHP sensitivity ( Figure 1B ). Therefore, a currents through ␣ 1A were unaffected by 10 M solutions model is unlikely where all four P regions form a (pseudo) of (Ϯ)-Bay K 8644 and (Ϯ)-isradipine ( Figure 2C) . symmetrical interaction site. DHP-agonist and DHP-antagonist sensitivity could be restored by changing the I Ba of chimeras Lh and Ls were stimulated by the DHP (Left column) Families of IBa currents shown for L-type chimeras Lh (A) and Ls (B) and for ␣1A (C) were recorded in 10 mV increments at test potentials ranging from Ϫ30 to ϩ20 mV from a holding potential of Ϫ80 mV. Currents had threshold potentials in the range of Ϫ40 to Ϫ20 region from segment IIIS1 through IIIS5 of AL2 from not agonist-) sensitive chimera AL13 demonstrates that L-type sequence is required only within a fraction of the class A to L-type sequence yielding chimera AL3 (Fig-IVS5 -IVS6 linker to mediate antagonist sensitivity. These ure 1). This suggested an essential role of IIIS1-IIIS5 (or results extend the findings of Tang et al. (1993) , as we at least parts of it) for DHP action. Moreover, restoration can show that in repeat IV only sequence differences of DHP sensitivity in chimera AL3 also indicated that within IVS6 account for agonist sensitivity, whereas the the carboxy-terminal tail of the ␣ 1 subunit has no essen-N-terminal half of the IVS5-IVS6 linker of carp ␣ 1S contribtial role in the formation of the DHP binding pocket.
utes also to DHP antagonist sensitivity. After replacement of the IVS5-IVS6 linker plus segTo further refine the role of repeat III, we swapped ment IVS6 of AL3 by class A sequence to create chimera segment IIIS6 from L-type to class A sequence (chimera AL4, the DHP agonist and antagonist sensitivity was AL11). This eliminated DHP antagonist and agonist senremoved ( Figure 1B ), which in accordance with the resitivity. Tang et al. (1993) replaced the first 9 amino acids sults of previous peptide mapping and chimeric deletion of transmembrane segment IIIS6 in ␣1C with ␣1A sequence studies (Nakayama et al., 1991; Striessnig et al., 1991;  without detectable effect on DHP sensitivity (their chiTang et al. , 1993) confirms that this part of repeat IV is mera CBC3). As we completely replaced IIIS6, the amino an essential element for DHP interaction.
acids responsible for DHP sensitivity have to be grouped In chimera AL5, repeat II, the I-II linker, and the between residues in positions 10-25 in IIIS6 of the corre-C-terminal half of IS6 of chimera AL3 were replaced by sponding ␣ 1C sequence. All of the remaining intracellular ␣ 1A sequence ( Figure 1A ). As DHP sensitivity was fully sequences could be removed from chimera AL9 without preserved in AL5 ( Figure 1B ), the sequence divergence loss of DHP sensitivity resulting in our minimum chimera, between L-type and class A channels within this region AL12s. The sensitivity of AL12 chimeras to (Ϯ)-Bay K does not account for the differences in DHP sensitivity.
8644 and (Ϯ)-isradipine was preserved, irrespective of Unfortunately, at this point we were unable to test the the source of L-type sequence used (␣ 1C, ␣1S; yielding importance of repeat I, as the expression of chimeras AL12h and AL12s, respectively; Figures 1A and 1B). Furcomposed of repeat I from ␣ 1A and repeat III from ␣ 1S ther replacement of L-type sequence within the P region did not yield functional channels. This result was obas well as S6 in repeat III (see chimeras AL14 and AL15) tained with several independent polymerase chain reacyielded DHP agonist-and DHP antagonist-insensitive tion (PCR) products. It could not be explained by PCRchannels (Figure 1 ), demonstrating the importance induced changes in the DNA sequence as confirmed by of these regions for the formation of the DHP interac-DNA sequencing of PCR-generated repeat I cDNAs.
tion site. As a next step, we further reduced the amount of L-type sequence of repeat III starting from chimera AL5.
Properties of the Minimal Chimera AL12s
Evidence for an important role of segments IIIS5 and Of the AL12 construct sequences, 90% comprise ␣ 1A IIIS6 and the IIIS5-IIIS6 linker was demonstrated by the sequence. The current kinetics of the studied chimeras loss of DHP sensitivity in AL6, where the stretch from closely resemble those of ␣ 1A ( Figure 1A and Figure 3 ); IIIS5-IIIS6 was switched to class A sequence. Because but, in contrast, the currents are sensitive to DHPs as L-type sequence only within the P region and S6 in exemplified for AL12s in Figures 3A-3F. Current increase repeat III, but excluding IIIS5, was not sufficient to create by (Ϯ)-Bay K 8644 ( Figure 3A ) or by DHP agonist (ϩ)-DHP sensitivity in chimeras AL1 and AL2, the results with 202-791 ( Figure 3E ) is associated with the typical shifts AL6 suggest the importance of IIIS5. By constructing in the maximum of the I-V curves toward more negative further chimeras (AL7 and AL8), we could exclude the potentials and similar changes in current kinetics as following sequence stretches as contributing to DHP found for chimeras Lh and Ls (see Figure 2 ). Current site formation: the cytoplasmic linker between repeats inhibition by isradipine was concentration dependent II and III, the region from segments IIIS1 to IIIS2 (chimera and stereoselective ( Figures 3C and 3D ) and occurred AL7), and the region from IIIS3 to IIIS4 (chimera AL8).
with similar apparent potency as block of currents mediAfter L-type sequences in repeat III were significantly ated by ␣ 1C ( Figure 3D ). We found no evidence for major reduced in chimera AL8, the swapping of repeat I from differences in DHP sensitivity between AL12s and ␣ 1C L-type to class A sequence was tolerated, yielding chi-( Figure 3D ). mera AL9, which formed DHP-sensitive channels. AL9 FPL 64176 is a novel benzoyl pyrrole L-type channel was then further modified to refine the roles of transagonist structurally unrelated to DHPs. Radioligand membrane segments IVS6 and IIIS6 and of the remaining binding studies indicate (Kunze and Rampe, 1992 ; Ginap cytoplasmic sequences. Changing segments IVS6 of et al., 1993) that FPL 64176 labels a site distinct from AL9 into class A sequence (chimera AL10) resulted in DHPs. Interestingly, FPL 64176 sensitivity is absent in the complete loss of sensitivity for the DHP agonist ␣1A (data not shown; but see Sather et al., 1993) but Bay K 8644, whereas the sensitivity for the antagonist was introduced into chimera AL12s ( Figure 3G ). This suggests that critical determinants of the FPL 64176 isradipine was retained. Similarly the antagonist-(but (Wheeler et al., 1994; Randall and Tsien, 1995) . Q-type currents in Xenopus oocytes are blocked to a model of minimal L-type sequence requirements for the formation of the DHP binding pocket as depicted by the spider toxin -Agatoxin IVA (-Aga IVA; IC 50 ϭ 200-1000 nM; Sather et al., 1993; Stea et al., 1994) and in Figures 5A and 5B. According to a molecular model of voltage gated cation channels (Guy and Conti, 1990 ) by the marine snail toxin -conotoxin MVIIC (-CTx MVIIC; IC50 Ͼ 100 nM; Sather et al., 1993) . Introduction these sequence stretches are believed to participate directly in the formation of the ion conducting pathway of L-type sequence into ␣1A (chimera AL12s) did not affect the sensitivity to these toxins. Block of AL12s by or to be located close to the extracellular pore opening ( Figure 5C ). A further reduction of L-type sequence in the two toxins was similar to the block observed for ␣1A and is exemplified for -Aga-IVA in Figures 4B and 4C .
repeat III resulted in a loss of DHP effects, suggesting that structural determinants for both DHP agonist and As expected (Sather et al., 1993) , ␣ 1C (expressed as Lh) was toxin insensitive ( Figure 4A ). Similar to the -conoantagonist interaction reside close to pore-forming regions in repeat III. The second DHP interaction site toxin GVIA block of N-type channels (Ellinor et al., 1994) , these peptide toxins most likely interact with the channel formed by residues in repeat IV is able to discriminate between channel activators and blockers: critical deterat the outer entrance of the ionic pore. We therefore consider the two pore-forming linkers of ␣ 1A , which were minants for DHP agonists are located within transmembrane segment IVS6 of L-type channels, whereas replaced by L-type sequences in AL12s to create the DHP sensitivity, as insignificant for toxin interaction.
L-type-channel-specific residues support DHP antagonist action within the N-terminal half of the IVS5-IVS6 linker. Functional studies have provided evidence for Discussion distinct DHP agonist and antagonist interaction sites (Kamp et al., 1989; Lacerda and Brown, 1989 ; Hughes ␣1 Subunit Regions Responsible for DHP Sensitivity et al., 1990) . DHPs induce a variety of changes in Ca 2ϩ channel gating and different channel state models have By generating a variety of chimeric ␣1 constructs between DHP-sensitive and DHP-insensitive ␣ 1 subunits, been proposed to explain kinetic effects on single channel and whole cell Ca 2ϩ channel currents (Bean, 1984 ; we succeeded in introducing DHP sensitivity into the a priori DHP-insensitive ␣ 1A subunit. L-type sequence Hess et al., 1984; Sanguinetti et al., 1986; before ( 1989; Lacerda and Brown, 1989; Marks and Jones, 1992 ; pocket seems not to interfere with the toxin interaction site(s). However, we cannot rule out slight changes in Bechem and Hoffmann, 1993) . The contribution of distant portions of primary structure for the formation of a the DHP affinity of the recombinant DHP receptor site in our AL12 chimeras unresolved by functional expresdrug binding site may facilitate ''allosteric'' effects on L-type channel function, promoting closed (antagonist) sion in Xenopus oocytes. Fourth, by constructing chimeras Ls and AL12s, we provide evidence that the preor open (agonist) channel conformations. Such allosteric effects may be most easily exerted by interaction at the viously cloned ␣1 subunit from carp (Cyprinus carpio) skeletal muscle belongs to the DHP-sensitive family of interface of protein subunits, as has been shown for allosteric enzymes (Sprang et al., 1987 ; Georgiadis et ␣ 1 subunits-something that had not been directly supported by functional expression studies. al., 1992). As the homologous repeats I-IV of the ␣ 1 subunit can be regarded as individual channel subunits
We conclude that the most important structural determinants for DHP sensitivity reside within the transposed connected by cytoplasmic loops, DHP binding involving repeats III and IV may promote conformational changes L-type sequence stretches of chimeras AL12. However, we cannot completely exclude the possibility that, when of tertiary structure more efficiently than by interaction within only one repeat. It is, however, interesting to note bound to the channel with high affinity, the DHP molecule interacts with additional amino acids outside these that the typical changes in current kinetics produced by agonist and antagonist DHPs require structural eleregions that are also provided by the ␣1A primary structure. For several reasons the identification of such resiments that are localized in channel repeats III and IV, whereas molecular determinants for activation and inacdues will be difficult. One possible approach consists in the construction of chimeras analogous to AL12 but tivation have been localized in repeat I of the ␣1 subunit Nakai et al., 1994; using a different DHP-insensitive ␣ 1 subunit (e.g., ␣ 1B ) as a host sequence. The high sequence homology among 1994; but see Wang et al., 1995) .
In the present work, we extend previous findings connon-L-type ␣ 1 subunits is the main drawback for this approach. Alternatively, alanine scanning mutagenesis cerning the localization of the DHP receptor domain obtained with antibody mapping (Nakayama et al., 1991; (Ragsdale et al., 1994) can be carried out but would require systematic mutation of a large number of residues. Striessnig et al., 1991) or chimeric constructs (Tang et al., 1993) . First, our data provide-by a constructive chimeric approach-direct evidence for the involvement of residues within repeat III for DHP agonist and antagoRepeat III Participates in the Formation of the DHP Binding Pocket nist sensitivity. Second, we directly demonstrate that portions of the IVS5-IVS6 linker mediate DHP antagonist Closer inspection of the sequence within the regions conferring DHP sensitivity to AL12 chimeras (Figure 6 ) sensitivity. Third, our results show that receptors not only for peptide toxins (Gross et al., 1994) but also for revealed an overall sequence identity of 62% between ␣1C and carp ␣1S. The amino acid identities between these small nonpeptidergic drugs can be successfully transferred between related ion channels. Obviously, the re-␣ 1 subunits and ␣ 1A were 46% and 41%, respectively. A sequence alignment of the respective sequences is maining ‫%09ف‬ of ␣ 1A sequence of AL12s induces no steric distortion to the overall folding structure of a stedepicted in Figure 6 . All amino acid residues within the ␣ 1A sequence that were not conserved in one of both reoselective DHP binding pocket. On the other hand, because the ␣ 1A -specific sensitivity for peptide toxins DHP-sensitive ␣ 1 subunits used in our study are highlighted. Among those, asterisks indicate residues that was not impaired, the introduction of the DHP binding (Mikami et al., 1989) . Marked sequence stretches CBC3 and CBC7 refer to the chimeric constructs analyzed by Tang et al. (1993) . Arrows mark transitions between L-type and class A sequence of the constructs indicated above the arrows (see also Figure 1A ). Residues within the ␣ 1A sequence not found in one of either DHP-sensitive ␣ 1 subunits studied are highlighted. Asterisks indicate residues identical within all L-type and also identical within all ''non-L-type'' channels cloned so far, but different between L-type and non-L-type channels.
were identical within all L-type channels and also identiamino acids must reside between positions 1414 and 1450 (␣ 1C ). This region includes a highly acidic 8 amino cal within all ''non-L-type'' channels cloned so far, but that were heterologous comparing L-type with non-Lacid residue insert in ␣ 1A , as well as 17 residues heterologous to our DHP-sensitive subunits. type channels. These residues are clustered especially within transmembrane segments IIIS5 and IIIS6 and are Additional residues between positions 1454 and 1498 (␣1C numbering) are essential to create agonist (Bay K major candidates for further mutational analyses. From the DHP insensitivity of chimeras AL1, AL2, AL6, AL11, 8644) sensitivity. Concerning transmembrane segment IVS6, agonist sensitivity is restricted to 7 amino acid AL14, and AL15, we conclude that residues in IIIS5, in the IIIS5-IIIS6 linker, and in IIIS6 are required for forming differences. As DHP agonists are believed to open the the DHP interaction site in repeat III. As previously channel via formation of a hydrogen bond (Triggle et al., shown, the sequence stretch between SS2 in repeat III 1991), we consider tyrosine (1490) as the most likely and the N-terminal portion of IIIS6 (Figure 6 ) (chimera interaction site (Figure 6 ). CBC3 by Tang et al., 1993) can be replaced by ␣ 1A seThe L-type sequence stretches important for DHP quence without effect on DHP agonist and antagonist sensitivity (as outlined in Figure 5 ) include all regions sensitivity. Therefore, amino acids determining DHP that have been previously identified as parts of the DHP sensitivity in repeat III must be located between posireceptor domain of purified rabbit skeletal muscle ␣1 tions 1063-1144 and 1180-1197 (numbers refer to ␣1C; subunits by photoaffinity labeling and antibody mapping Mikami et al., 1989) . (Nakayama et al., 1991; Striessnig et al., 1991) . The importance of IIIS6 and the IIIS5-IIIS6 linker has been predicted from these studies. Moreover, photolabeling with Differential Interaction of DHP Agonists and the DHP antagonist (ϩ)-[ 3 H]isradipine also predicted the Antagonists Within Repeat IV minor importance of IVS6 for DHP antagonist interacIn repeat IV, residues important for DHP agonist and tion, a finding confirmed by our results. In contrast to antagonist action can be predicted more precisely. The an interpretation of a preliminary study (Tang et al., sequence stretch supporting DHP antagonist sensitivity 1993), we consider antibody mapping analysis of photoin chimera AL13 is indicated ( Figures 1A, 5B, and 6 ).
labeled regions a very valuable tool to predict the posiAccordingly, ␣ 1C containing ␣ 1A sequence in chimera tions of drug receptor sites within ion channel proteins. CBC7 (see Figure 6 ) reported by Tang et al. (1993) supported DHP antagonist sensitivity. Thus, the crucial Mutational studies will mainly allow delineation of amino was coligated with the ligation product from the ApaI-NarI* fragment AL12(h/s) and AL13-AL15 (see Figure 1A) between the DHP-insensiof A (3949-4220) plus the NarI*-SalI fragment of S (2796-3317) into tive rabbit brain class A Ca 2ϩ channel (BI-2) ␣1A (A; Mori et al., 1991) the XhoI (1689A) and SalI (3317S) sites of AL5. and the DHP-sensitive L-type channels from carp skeletal muscle AL8 ␣ 1S (S; Grabner et al., 1991) and rabbit heart ␣1C-a (H; Mikami et al., . BamHI (5Ј polylinker-1456) H subclone in pBluescript SKϩ (StraClaI*-XbaI* fragment of AL9 (4925A-4307S) was coligated with the tagene). This modification of the 5Ј region leads to higher expression SpeI*-BglII fragment of A (5671-6185) into the ClaI* (3498S) and levels compared with unmodified ␣ 1C-a cDNA and was therefore rouBglII (6185A) sites of AL9. tinely used in our expression studies (Mitterdorfer et al., 1994 (Mitterdorfer et al., , 1995 AL11 Wang et al., 1995) .
A(1-1369), S(928-1046), A(1486-1723), S(1311-1376), A(1795-2424). To construct the following ␣1 chimeras (as depicted in Figure 1A) , SalI*-ClaI* fragment of A (4744-4925) was inserted into the SalI PCR was used to create either common or compatible (SalI-XhoI; (3317S) and ClaI* (4925A) sites of AL10. NsiI-PstI; XbaI-SpeI; HpaI-PvuII-EcoRV) restriction sites by introAL12s ducing silent mutations (mutational sites indicated by an asterisk)
A(1-1388), S(947-1082), A(1522-1723), S(1311-1402), A(1821-2424). or vast overlaps in using the ''gene SOEing'' technique (Horton et The ligation product from the NheI-HpaI* fragment of A (3543-4464) al., 1989) . cDNA amplification by PCR (Thermocycler 60, plus the PvuII*-SalI fragment of S (3028-3317) was coligated with was performed with 35 cycles at low stringency (1 min at 94ЊC, the ligation product from the SalI-HpaI* fragment of S (3317-3424) 30 s at 42ЊC, 1.5 min at 72ЊC) using proofreading Pfu-polymerase plus the EcoRV*-ClaI* fragment of A (4851-4925) into the NheI (Stratagene). 
AL15
Bechem, M., and Hoffmann, H. (1993) . The molecular-mode of action A(1-1369), S(928-1046), A(1486-1723), S(1311-1437), A(1856-2424 Birnbaumer, L., Campbell, K.P., Catterall, W.A., Harpold, M.M., HofChimeric constructs were verified by extensive restriction enzyme mann, F., Horne, W.A., Mori, Y., Schwartz, A., Snutch, T.P., Tanabe, mapping, by using at least two independent clones or by confirming T., and Tsien, R.W. (1994) . The naming of voltage-gated calcium their nucleotide composition by cDNA sequencing with the dideoxy channels. Neuron 13, 505-506. chain termination method (Sanger et al., 1977 (1988) . Sequence and expression of mRNAs encoding the ␣ 1 of 40 mM Ba(OH)2 or 2 mM Ba(OH)2 (''high barium'' and ''low barium '' and ␣ 2 subunits of a DHP-sensitive calcium channel. Science 241, solution, respectively), 40 mM N-methyl-D-glucamine, 10 mM 1661-1664. HEPES, and 10 mM glucose (pH adjusted to 7.4 with methanesulfonic acid). The recording chamber with a volume of 150 l was Georgiadis, M.M., Komiya, H., Chakrabarti, P., Woo, D., Kornuc, J.J., continuously perfused with a flow rate of 1 ml/min; drug-containing and Rees, D.C. (1992) . Crystallographic structure of the nitrogenase solutions were applied with identical flow rate. Leakage current iron protein from Azotobacter vinelandii. Science 257, 1653-1659. correction was performed either by subtracting the Cd 2ϩ -sensitive Ginap, T., Dooley, D.J., and Feuerstein, T.J. (1993) . The non-dihydrocurrent (10 M Cd 2ϩ added) or, digitally, by using average values pyridine L-type voltage-sensitive calcium channel activator FPL of scaled leakage currents elicited by hyperpolarizing voltage pulses 64176 enhances K ϩ -evoked efflux of [
